tiprankstipranks
Neurogene (NGNE)
NASDAQ:NGNE
US Market

Neurogene (NGNE) Similar Stocks

430 Followers

Other Large Cap Stocks Paying Dividends

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Apellis Pharmaceuticals
$4.80B
-11.43
-24.65%
11 Buy
3 Hold
0 Sell
Strong Buy
Ascendis Pharma
$7.82B
-14.33
58.35%
9 Buy
2 Hold
0 Sell
Strong Buy
Crinetics Pharmaceuticals
$4.23B
-14.23
168.89%
12 Buy
0 Hold
0 Sell
Strong Buy
Fate Therapeutics
$410.93M
-1.88
-16.52%
5 Buy
8 Hold
0 Sell
Moderate Buy
Neurogene
$552.70M
-16.04
148.38%
6 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
APLS
Apellis Pharmaceuticals
40.00
0.00
0.00%
ASND
Ascendis Pharma
137.04
48.04
53.98%
CRNX
Crinetics Pharmaceuticals
54.14
34.20
171.51%
FATE
Fate Therapeutics
3.89
-0.70
-15.25%
NGNE
Neurogene
45.95
31.17
210.89%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis